메뉴 건너뛰기




Volumn 19, Issue 2, 2006, Pages 106-117

Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in four- to eleven-year-old children with asthma: A randomized, double-blinded, placebo-controlled study

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; HYDROCORTISONE; PLACEBO; SALBUTAMOL;

EID: 33745686484     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2006.19.106     Document Type: Article
Times cited : (3)

References (24)
  • 4
    • 0038386610 scopus 로고    scopus 로고
    • Weighing the risks of treatment versus nontreatment in pediatric asthma
    • Spahn JD, Covar RA. Weighing the risks of treatment versus nontreatment in pediatric asthma. Pediatr Clin North Am 2003; 50:677-695.
    • (2003) Pediatr Clin North Am , vol.50 , pp. 677-695
    • Spahn, J.D.1    Covar, R.A.2
  • 6
    • 33745735794 scopus 로고    scopus 로고
    • Challenges in assessing outcomes for pediatric asthma
    • Szefler SJ. Challenges in assessing outcomes for pediatric asthma. J Allergy Clin Immunol 2001; 105:8456-8464.
    • (2001) J Allergy Clin Immunol , vol.105 , pp. 8456-8464
    • Szefler, S.J.1
  • 7
    • 0036164282 scopus 로고    scopus 로고
    • Inflammation in childhood asthma and other wheezing disorders
    • Lemanske RJ Jr. Inflammation in childhood asthma and other wheezing disorders. Pediatrics 2002; 109:368-372.
    • (2002) Pediatrics , vol.109 , pp. 368-372
    • Lemanske Jr., R.J.1
  • 9
    • 0029593326 scopus 로고
    • Eosinophils and basophilic cells in sputum and nasal smears taken from infants and young children during asthma
    • Nagayama Y, Odazima Y, Nakayama S, Toba T, Funabashi S. Eosinophils and basophilic cells in sputum and nasal smears taken from infants and young children during asthma. Pediatr Allergy Immunol 1995; 6:204-208.
    • (1995) Pediatr Allergy Immunol , vol.6 , pp. 204-208
    • Nagayama, Y.1    Odazima, Y.2    Nakayama, S.3    Toba, T.4    Funabashi, S.5
  • 10
    • 0018128604 scopus 로고
    • Ultrastructure of airways in children with asthma
    • Cuz E, Levison H, Cooper DM. Ultrastructure of airways in children with asthma. Histopathology 1978; 2:407-421.
    • (1978) Histopathology , vol.2 , pp. 407-421
    • Cuz, E.1    Levison, H.2    Cooper, D.M.3
  • 13
    • 0038664288 scopus 로고    scopus 로고
    • Fluticasone propionate 100 μg BID using a non-CFC propellant, HFA 134a, in asthmatic children
    • Lyttle B, Gilles J, Panov M, Emery KA, Wixon C. Fluticasone propionate 100 μg BID using a non-CFC propellant, HFA 134a, in asthmatic children. Can Repsir J 2003; 10:103-109.
    • (2003) Can Repsir J , vol.10 , pp. 103-109
    • Lyttle, B.1    Gilles, J.2    Panov, M.3    Emery, K.A.4    Wixon, C.5
  • 14
    • 0033674210 scopus 로고    scopus 로고
    • Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant
    • Mackie AE, McDowall JE, Ventresca P, Bye A, Falcoz C, Daky-Yates PT. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant. Clin Pharmacokinet 2000; 39(Suppl 1):17-22.
    • (2000) Clin Pharmacokinet , vol.39 , Issue.SUPPL. 1 , pp. 17-22
    • Mackie, A.E.1    McDowall, J.E.2    Ventresca, P.3    Bye, A.4    Falcoz, C.5    Daky-Yates, P.T.6
  • 15
    • 0033895193 scopus 로고    scopus 로고
    • Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA-134a pressurized metered dose inhaler to patients with severe asthma
    • Ayres JG, Millar AB, Sykes AP. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA-134a pressurized metered dose inhaler to patients with severe asthma. Respir Med 2000; 94(Suppl B):S42-S50.
    • (2000) Respir Med , vol.94 , Issue.SUPPL. B
    • Ayres, J.G.1    Millar, A.B.2    Sykes, A.P.3
  • 16
    • 0033908040 scopus 로고    scopus 로고
    • Clinical efficacy and safety of fluticasone propionate 250 meg twice daily administered via a HFA-134a pressurized metered dose inhaler to patients with mild to moderate asthma
    • Tonnel AB, Bons J, Legendre M, Prudhomme A, Bugnas B, Evano-Celli I, Stuart AM. Clinical efficacy and safety of fluticasone propionate 250 meg twice daily administered via a HFA-134a pressurized metered dose inhaler to patients with mild to moderate asthma. Respir Med 2000; 94(Suppl B):S29-34.
    • (2000) Respir Med , vol.94 , Issue.SUPPL. B
    • Tonnel, A.B.1    Bons, J.2    Legendre, M.3    Prudhomme, A.4    Bugnas, B.5    Evano-Celli, I.6    Stuart, A.M.7
  • 17
    • 0033873221 scopus 로고    scopus 로고
    • Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA-134a pressurized metered-dose inhaler to patients with moderate to severe asthma
    • Perruchoud AP, Lundback B, Yigla M, Sykes AP. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA-134a pressurized metered-dose inhaler to patients with moderate to severe asthma. Respir Med 2000; 94(Suppl B):S35-41.
    • (2000) Respir Med , vol.94 , Issue.SUPPL. B
    • Perruchoud, A.P.1    Lundback, B.2    Yigla, M.3    Sykes, A.P.4
  • 19
    • 0031902618 scopus 로고    scopus 로고
    • Fluticasone propionate 50 meg BID versus 100 meg BID in the treatment of children with persistent asthma
    • Katz Y, Lebas FX, Medley HV, Robson R. Fluticasone propionate 50 meg BID versus 100 meg BID in the treatment of children with persistent asthma. Clin Ther 1998; 20:424-437.
    • (1998) Clin Ther , vol.20 , pp. 424-437
    • Katz, Y.1    Lebas, F.X.2    Medley, H.V.3    Robson, R.4
  • 20
    • 0031845606 scopus 로고    scopus 로고
    • Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma
    • Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol 1998; 102:32-38.
    • (1998) J Allergy Clin Immunol , vol.102 , pp. 32-38
    • Peden, D.B.1    Berger, W.E.2    Noonan, M.J.3    Thomas, M.R.4    Hendricks, V.L.5    Hamedani, A.G.6    Mahajan, P.7    House, K.W.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.